Is DMPHF or RYLD a better dividend investment in 2026?

DMPHF currently yields 2.17% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between DMPHF and RYLD?

DMPHF has a forward dividend yield of 2.17% ($1.05/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 10.22 percentage points.

Home › Compare › DMPHF vs RYLD

DMPHF vs RYLD: Dividend Comparison 2026

DMPHF yields 2.17% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $18.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DMPHF

● Live price

2.17%

Share price

$48.60

Annual div

$1.05

5Y div CAGR

14%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.8K

Annual income

$1,051.08

Full DMPHF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — DMPHF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DMPHF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DMPHF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DMPHF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMPHF

Annual income on $10K today (after 15% tax)

$184.42/yr

After 10yr DRIP, annual income (after tax)

$893.42/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, RYLD beats the other by $1,387.12/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMPHF + RYLD for your $10,000?

DMPHF: 50%RYLD: 50%

100% RYLD50/50100% DMPHF

Portfolio after 10yr

$36.0K

Annual income

$1,867.03/yr

Blended yield

5.18%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMPHF buys

RYLD buys

No recent congressional trades found for DMPHF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDMPHFRYLD

Forward yield	2.17%	12.39% ✓
Annual dividend / share	$1.05	$1.81 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	14% ✓	0%
Portfolio after 10y	$26.8K	$45.3K ✓
Annual income after 10y	$1,051.08	$2,682.98 ✓
Total dividends collected	$5.6K	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: DMPHF vs RYLD ($10,000, DRIP)

Year	DMPHF Portfolio	DMPHF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$10,947	$247.34	$11,939	$1,239.34	$992.00 → RYLD
2	$12,002	$288.49	$14,158	$1,382.89	$2.2K → RYLD
3	$13,179	$336.98	$16,682	$1,532.59	$3.5K → RYLD
4	$14,496	$394.23	$19,537	$1,687.64	$5.0K → RYLD
5	$15,973	$461.99	$22,752	$1,847.20	$6.8K → RYLD
6	$17,633	$542.36	$26,355	$2,010.43	$8.7K → RYLD
7	$19,505	$637.91	$30,376	$2,176.45	$10.9K → RYLD
8	$21,623	$751.80	$34,847	$2,344.43	$13.2K → RYLD
9	$24,024	$887.92	$39,800	$2,513.54	$15.8K → RYLD
10	$26,757	$1,051.08	$45,269	$2,682.98	$18.5K → RYLD

DMPHF vs RYLD: Complete Analysis 2026

DMPHF — Stock

Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

Full DMPHF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this DMPHF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMPHF vs SCHD DMPHF vs JEPI DMPHF vs O DMPHF vs KO DMPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.